Effect of GLP-1 on Postprandial Lipid Metabolism
Public ClinicalTrials.gov record NCT01760772. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Role of GLP-1 in Lipid Metabolism in Healthy Subjects and in Subjects After Bariatric Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Individuals with obesity have an increased risk for heart disease and diabetes. There are current drugs on the market that target the hormone, Glucagon like peptide-1 (GLP-1) to treat diabetes. The investigators want to determine if targeting this hormone will also help people with high cholesterol and triglycerides. In this study, the investigators are looking at the role of GLP-1 in healthy subjects and subjects that have had bariatric surgery.
Study identification
- NCT ID
- NCT01760772
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013
- Primary completion
- Jan 31, 2015
- Completion
- Jan 31, 2015
- Last update posted
- Jan 3, 2013
2013 – 2015
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Veteran's Affairs Clinical Research Unit | Cincinnati | Ohio | 45220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Heart Disease trials
Other public records listing Heart Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT07388355: A Usability Study of a Multi-channel ECG Monitoring Device Recruiting
- NCT07130994: Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US) Not yet recruiting
- NCT07380243: Pathways to Prevention Food-is-Medicine Trial Recruiting
- NCT07351656: A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound Recruiting
- NCT07240831: Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Recruiting
- NCT00341237: Personalized Environment and Genes Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01760772, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2013 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01760772 live on ClinicalTrials.gov.